TCG Crossover Management »

Cullinan Oncology shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.8M 407k 14.21

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs (CNTA)
Dianthus Therapeutics Comm (DNTH)
Tyra Biosciences Comm (TYRA)
Immunovant Comm (IMVT)
Biocryst Pharmaceuticals Comm (BCRX)
Mirum Pharmaceuticals Comm (MIRM)
Vor Biopharma Comm (VOR)
Spyre Therapeutics Comm (SYRE)
Amylyx Pharmaceuticals Comm (AMLX)
Disc Medicine Comm (IRON)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Vanguard Capital Management
Blue Owl Capital Holdings
State Street Corporation
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Siren
Nextech Invest

View all funds holding Cullinan Oncology